The overall goal is to study the immune response to SARS-CoV-2 infection over the period of one year in the blood of a representative cohort of ETH students/employees.
Study Type
OBSERVATIONAL
Enrollment
2,910
ETH
Zurich, Switzerland
seroprevalence as well as the titer of serum antibodies (IgM, IgG and IgA) targeting SARS-CoV-2 antigens
Time frame: 12 months
the property of peripheral blood mononuclear cells before and after an infection with SARS-CoV-2 as opposed to other pathogens
Time frame: 12 months
the property of IgM and IgA antibody titers against the nucleocapsid protein of SARS-CoV-2 in symptomatic as well as asymptomatic COVID-19 infections over the course of time following an infection
Time frame: 12 months
the immune response to common-cold (corona)virus and influenza virus infections in patients with COVID-19 infections
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.